Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katelyn W Sylvester

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Future Cardiology|October 25, 2018
Betrixaban in the prevention of venous thromboembolism in medically ill patientsKatelyn W Sylvester, Jean M Connors
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 15, 2018
Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated HeparinClara Ting, Katelyn W Sylvester, James W Schurr
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 22, 2016
Direct Thrombin Inhibitor for LVAD Thrombosis: A Closer LookJessica Rimsans, Katelyn W Sylvester, Jean M Connors
Vascular Health and Risk Management|May 23, 2013
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular eventsKatelyn W Sylvester, Judy Wm Cheng, Mandeep R Mehra
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 25, 2015
Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced ThrombocytopeniaBrianne M Ritchie, Jean M Connors, Katelyn W Sylvester
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2016
Development of a Predictive Nomogram for the Change in PT/INR Upon Discontinuation of Bivalirudin as a Bridge to WarfarinBenjamin Hohlfelder, David DeiCicchi, Katelyn W Sylvester, et al.
The Annals of Pharmacotherapy|May 21, 2014
Pharmacy Response to the Boston Marathon Bombings at a Tertiary Academic Medical CenterKatelyn W Sylvester, Megan A Rocchio, Caryn Belisle, et al.
Research and Practice in Thrombosis and Haemostasis|May 20, 2021
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort studyLachelle D Weeks, Katelyn W Sylvester, Jean M Connors, et al.
Journal of Thrombosis and Thrombolysis|January 20, 2017
Prospective evaluation of a bivalirudin to warfarin transition nomogramBenjamin Hohlfelder, Katelyn W Sylvester, Jessica Rimsans, et al.
Journal of Pharmacy Practice|October 12, 2017
Utilization of an Integrated Electronic Health Record in the Emergency Department to Increase Prospective Medication Order Review by PharmacistsMegan E Barra, Sarah E Culbreth, Katelyn W Sylvester, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Future Cardiology|October 25, 2018
Betrixaban in the prevention of venous thromboembolism in medically ill patientsKatelyn W Sylvester, Jean M Connors
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 15, 2018
Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated HeparinClara Ting, Katelyn W Sylvester, James W Schurr
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 22, 2016
Direct Thrombin Inhibitor for LVAD Thrombosis: A Closer LookJessica Rimsans, Katelyn W Sylvester, Jean M Connors
Vascular Health and Risk Management|May 23, 2013
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular eventsKatelyn W Sylvester, Judy Wm Cheng, Mandeep R Mehra
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 25, 2015
Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced ThrombocytopeniaBrianne M Ritchie, Jean M Connors, Katelyn W Sylvester
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2016
Development of a Predictive Nomogram for the Change in PT/INR Upon Discontinuation of Bivalirudin as a Bridge to WarfarinBenjamin Hohlfelder, David DeiCicchi, Katelyn W Sylvester, et al.
The Annals of Pharmacotherapy|May 21, 2014
Pharmacy Response to the Boston Marathon Bombings at a Tertiary Academic Medical CenterKatelyn W Sylvester, Megan A Rocchio, Caryn Belisle, et al.
Research and Practice in Thrombosis and Haemostasis|May 20, 2021
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort studyLachelle D Weeks, Katelyn W Sylvester, Jean M Connors, et al.
Journal of Thrombosis and Thrombolysis|January 20, 2017
Prospective evaluation of a bivalirudin to warfarin transition nomogramBenjamin Hohlfelder, Katelyn W Sylvester, Jessica Rimsans, et al.
Journal of Pharmacy Practice|October 12, 2017
Utilization of an Integrated Electronic Health Record in the Emergency Department to Increase Prospective Medication Order Review by PharmacistsMegan E Barra, Sarah E Culbreth, Katelyn W Sylvester, et al.
Pageof 5